Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Acetylcholinesterase, Butyrylcholinesterase, Paraoxonase Activity, and Cardiovascular Risk Factors in Patients Treated With Intravitreal Bevacizumab

NCT07550777 is registered in ClinicalTrials.gov with Ataturk University as lead sponsor.

NCT NCT07550777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07550777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Acetylcholinesterase, Butyrylcholinesterase, Paraoxonase Activity, and Cardiovascular Risk Factors in Patients Treated With Intravitreal Bevacizumab
Lead sponsor
Ataturk University
Phase
Observational
Overall status
Recruiting
Start date
November 3, 2025
Completion date
July 10, 2026
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age macular degeneration, diabete mellitus, retina vein occlusion